Interleukin-1β converting enzyme-like protease involvement in Fas- induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation- induced T cell death in HIV infection

Journal of Experimental Medicine

Volumn 186, Issue 8, 1997, Pages 1365-1372

  Katsikis, Peter D ^a   Garcia Ojeda, Marcos E ^a   Torres Roca, Javier F ^a   Tijoe, Iwan M ^a   Smith, Craig A ^b   Herzenberg, Leonore A ^a   Herzenberg, Leonard A ^a  

^a STANFORD UNIVERSITY   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DNA FRAGMENT; FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; LIGAND; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR; PROTEINASE; TRIPEPTIDE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 1; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HIV INFECTIONS; HUMANS; INTERLEUKIN-1; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTE SUBSETS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030731919     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.8.1365     Document Type: Article

References (49)

1. Meyaard, L., S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science (Wash. DC). 257:217-219.
2. Oyaizu, N., T.W. McCloskey, M. Coronesi, N. Chirmule, V.S. Kalyanaraman, and S. Pahwa. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 82:3392-3400.
3. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
4. Katsikis, P.D., E.S. Wunderlich, C.A. Smith, L.A. Herzenberg, and L.A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036.
5. + T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1759-1767.
6. Fauci, A.S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (Wash. DC). 262:1011-1018.
7. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C. . Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
8. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373:441-444.
9. Dhein, J., H. Walczak, C. Baumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (Lond.). 373:438-441.
10. Ju, S.T., D.J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (Lond.). 373:444-448.
11. Smith, C.A., T. Farrah, and R.G. Goodwill. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:959-962.
12. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.
13. Trauth, B.C., C. Klas, A.M. Peters, S. Matzku, P. Moller, W. Falk, K.M. Debatin, and P.H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Wash. DC). 245:301-305.
14. Alderson, M.R., R.J. Armitage, E. Maraskovsky, T.W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D.H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231-2235.
15. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Wash. DC). 265:528-530.
16. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (Lond.). 370:650-652.
17. Wiley, S.R., K. Schooley, P.J. Smolak, W.S. Din, C.P. Huang, J.K. Nicholl, G.R. Sutherland, T.D. Smith, C. Rauch, C.A. Smith, et al. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:673-682.
18. Pitti, R.M., S.A. Marsters, S. Ruppert, C.J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687-12690.
19. Katsikis, P.D., M.E. Garcia-Ojeda, E.S. Wunderlich, C.A. Smith, H. Yagita, K. Okumura, N. Kayagaki, M. Alderson, L.A. Herzenberg, and L.A. Herzenberg. 1996. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int. Immunol. 8:1311-1317.
20. Moore, W.A., and R.A. Kautz. 1986. Data analysis in flow cytometry. In Handbook of Experimental Immunology. Blackwell Scientific Publications, Oxford. 30.1-30.11.
21. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.). 375:78-81.
22. Los, M., M. Van de Craen, L.C. Penning, H. Schenk, M. Westendorp, P.A. Baeuerle, W. Droge, P.H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (Lond.). 375:81-83.
23. Enari, M., R.V. Talanian, W.W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.). 380: 723-726.
24. Dolle, R.E., D. Hoyer, C.V. Prasad, S.J. Schmidt, C.T. Helaszek, R.E. Miller, and M.A. Ator. 1994. P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy)methyl ketones. J. Med. Chem. 37:563-564.
25. Slee, E.A., H. Zhu, S.C. Chow, M. MacFarlane, D.W. Nicholson, and G.M. Cohen. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:21-24.
26. Pronk, G.J., K. Ramer, P. Amiri, and L.T. Williams. 1996. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science (Wash. DC). 271:808-810.
27. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, et al., 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell. 85:817-827.
28. Zhu, H., H.O. Fearnhead, and G.M. Cohen. 1995. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells. FEBS Lett. 374:303-308.
29. Fearnhead, H.O., D. Dinsdale, and G.M. Cohen. 1995. An interleukin-1 β-converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett. 375: 283-288.
30. Estaquier, J., M. Tanaka, T. Suda, S. Nagata, P. Golstein, and J.C. Ameisen. 1996. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood. 87:4959-4966.
31. Marsters, S.A., R.M. Pitti, C.J. Donahue, S. Ruppert, K.D. Bauer, and A. Ashkenazi. 1996. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr. Biol. 6:750-752.
32. Braun, M.Y., B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657-661.
33. Caruso, A., A. Cantalamessa, S. Licenziati, L. Peroni, E. Prati, F. Martinelli, A.D. Canaris, S. Folghera, R. Gorla, A. Balsari, et al., 1994. Expression of CD28 on CD8+ and CD4+ lymphocytes during HIV infection. Scand. J. Immunol. 40:485-490.
34. Choremi-Papadopoulou, H., V. Viglis, P. Gargalianos, T. Kordossis, A. Iniotaki-Theodoraki, and J. Kosmidis. 1994. Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J. Acquir. Immune Defic. Syndr. 7:245-253.
35. Effros, R.B., R. Allsopp, C.P. Chiu, M.A. Hausner, K. Hirji, L. Wang, C.B. Harley, B. Villeponteau, M.D. West, and J.V. Giorgi. 1996. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 10:F17-F22.
36. Fiorentino, S., M. Dalod, D. Olive, J.G. Guillet, and E. Gomard. 1996. Predominant involvement of CD8+CD28-lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J. Virol. 70:2022-2026.
37. Pan, G.H., K. O'Rourke, A.M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V.M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science (Wash. DC). 276:111-113.
38. Walczak, H., M.A. Degli-Esposti, R. Johnson, N. Boiani, M. Gerhart, P. Smolak, K. Schooley, M. Timour, J. Waugh, C.A. Smith, et al. 1997. Identification and characterization of a second apoptosis-mediating receptor for TRAIL. EMBO (Eur. Mol. Biol. Organ.). In press.
39. Degli-Esposti, M.A., P. Smolak, H. Walczak, J. Waugh, C.P. Huang, R. DuBose, R. Goodwin and C.A. Smith. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186:1165-1170.
40. Sarin, A., M.L. Wu, and P.A. Henkart. 1996. Different interleukin-1β converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184:2445-2450.
41. Katsikis, P.D., M.E. Garcia-Ojeda, L.A. Herzenberg, and L.A. Herzenberg. 1997. HIV Tat protein enhances activation but not Fas (CD95) induced peripheral blood T cell apoptosis in healthy individuals. Int. Immunol. 9:835-841.
42. Li, C.J., D.J. Friedman, C. Wang, V. Metelev, and A.B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science (Wash. DC). 268:429-431.
43. Vasilakos, J.P., T. Ghayur, R.T. Carroll, D.A. Giegel, J.M. Saunders, L. Quintal, K.M. Keane, and B.D. Shivers. 1995. IL-1β converting enzyme (ICE) is not required for apoptosis induced by lymphokine deprivation in an IL-2-dependent T cell line. J. Immunol. 155:3433-3442.
44. Smith, D.J., M.J. McGuire, M.J. Tocci, and D.L. Thiele. 1997. IL-1β convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms. J. Immunol. 158: 163-170.
45. Darmon, A.J., D.W. Nicholson, and R.C. Bleackley. 1995. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature (Lond.). 377:446-148.
46. Quan, L.T., M. Tewari, K. O'Rourke, V. Dixit, S.J. Snipas, G.G. Poirier, C. Ray, D.J. Pickup, and G.S. Salvesen. 1996. Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc. Natl. Acad. Sci. USA. 93:1972-1976.
47. Martin, S.J., G.P. Amarante-Mendes, L. Shi, T.H. Chuang, C.A. Casiano, G.A. O'Brien, P. Fitzgerald, E.M. Tan, G.M. Bokoch, A.H. Greenberg, et al., 1996. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO (Eur. Mol. Biol. Organ.) J. 15:2407-2416.
48. Mogil, R.J., L. Radvanyi, R. Gonzalez-Quintial, R. Miller, G. Mills, A.N. Theofilopoulos, and D.R. Green. 1995. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7:1451-1458.
49. Sieg, S., D. Smith, Z. Yildirim, and D. Kaplan. 1997. Fas ligand deficiency in HIV disease. Proc. Natl. Acad. Sci. USA. 94:5860-5865.